Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Chantix

Drug Neuroscience;Tobacco Dependence

NDC 0069-0471-02

Open in the dashboard

General payments

$1,581,064

133,782 payments

Research payments

$597,122

27 payments

Through program year 2019, $1,581,064 in general payments and $597,122 in research payments were reported against Chantix (Neuroscience;Tobacco Dependence).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $1,581,064 133,782
2019 Research $597,122 27

Breakdown

Who paid General payments · program year 2019
  1. Pfizer Inc. $1,573,091 133,246 payments
  2. PBG Puerto Rico LLC $5,706 377 payments
  3. Pfizer Pharmaceuticals LLC $2,268 159 payments
Top recipients General payments · program year 2019
  1. Louis Depalo Pulmonary Disease · New York, NY $19,448 1% · 5 payments
  2. Neal Benowitz Internal Medicine · San Francisco, CA $9,622 <1% · 7 payments
  3. Bart Denys Interventional Cardiology · Thibodaux, LA $5,591 <1% · 25 payments
  4. Serena Tonstad Public Health & General Preventive Medicine · Loma Linda, CA $5,070 <1% · 3 payments
  5. Robert Anthenelli Addiction Psychiatry · San Diego, CA $3,400 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Family Medicine $694,875 45% · 14,608 practitioners
  2. Internal Medicine $553,523 36% · 10,833 practitioners
  3. Cardiovascular Disease Internal Medicine $94,176 6% · 3,073 practitioners
  4. Interventional Cardiology Internal Medicine $38,358 2% · 1,019 practitioners
  5. Pulmonary Disease Internal Medicine $33,544 2% · 559 practitioners

The top 5 of 126 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $114,284 7% · 2,402 recipients
  2. Pennsylvania $107,966 7% · 1,913 recipients
  3. New York $107,267 7% · 1,932 recipients
  4. Florida $97,583 6% · 2,584 recipients
  5. Illinois $91,461 6% · 1,534 recipients

The top 5 of 53 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

133,782 general · 27 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record